To ease depression, cancer patients will get group therapy — and a psychedelic drug

As medical director of the Aquilino Cancer Center, Dr. Manish Agrawal has seen the progress made possible by cancer research.

Death rates from cancer have declined steadily among men and women, and for most common cancers, including lung, breast, and prostate cancers.

“The longer you’re in practice. you realize that we do a really good job with cancer-directed treatment,” Dr. Agrawal says.

But Dr. Agrawal has also seen patients struggle with depression and anxiety. Some cannot get the help they need.

“There’s so much emotional and psychological suffering that cancer patients and their families go through,” he says, “We never fully address that.”

Now, a small group of patients at Aquilino, an outpatient treatment center at Shady Grove Adventist Hospital in Rockville, MD, will have the chance to try something new — treatment that combines group therapy with a single dose of psilocybin, a psychedelic drug that is the active ingredient in so-called magic mushrooms. Psilocybin is illegal, but the government gives select researchers permission to use it in controlled clinical settings.

You can read the rest of this story on Medium